PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 111 filers reported holding PLIANT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,091,397 | -52.7% | 62,941 | -50.6% | 0.01% | -54.5% |
| Q2 2023 | $2,308,506 | -48.3% | 127,401 | -24.1% | 0.01% | -50.0% |
| Q1 2023 | $4,463,294 | +33.5% | 167,793 | -3.0% | 0.02% | +15.8% |
| Q4 2022 | $3,343,897 | +53.5% | 172,990 | +65.8% | 0.02% | +58.3% |
| Q3 2022 | $2,179,000 | – | 104,307 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
| CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
| TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
| Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
| Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
| Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
| HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
| Grace Capital | 48,058 | $808,000 | 0.50% |
| Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
| Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |